Quick Answer
Compass Therapeutics, Inc. reported Total Assets of $219.59 million for fiscal year 2025.
Compass Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $219.59M | +56.4% |
| 2024 | $140.40M | -10.5% |
| 2023 | $156.88M | -21.4% |
| 2022 | $199.65M | +29.8% |
| 2021 | $153.76M | +196.2% |
| 2020 | $51.91M | +1386041.5% |
| 2020 | $3.7K | -100.0% |
| 2019 | $30.38M | +624252.7% |
| 2019 | $4.9K | +19364.0% |
| 2018 | $25.00 | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $231.26M | +55.1% | +98.2% |
| June 30, 2025 | $116.70M | -25.0% | -11.2% |
| March 31, 2025 | $131.45M | -18.4% | -6.4% |
| December 31, 2024 | $140.40M | -10.5% | -5.9% |
| September 30, 2024 | $149.15M | -12.3% | -4.2% |
| June 30, 2024 | $155.61M | -13.2% | -3.4% |
| March 31, 2024 | $161.14M | -14.3% | +2.7% |
| December 31, 2023 | $156.88M | -21.4% | -7.7% |
- Compass Therapeutics, Inc. showed an increase of +56.4% in Total Assets compared to the prior fiscal year.
- Over the 2018–2025 period, Compass Therapeutics, Inc.’s total assets has grown by 878351900.0% (from $25.00 to $219.59 million).
- The most recent figure is from Compass Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: